Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Giroptic makes a splash with Facebook

    At Facebook’s annual conference in California, an enthusiastic Mark Zuckerberg gave a Giroptic iO camera to every attendee—and wrote a $1 million check to the Lille-based start-up.

    Arcelor Mittal Dunkerque investing in performance

    Steelmaker earmarks €31 million for continuous hot mill at Dunkerque plant.

    All news

    Lille’s Macopharma uses cell therapy to fight diabetes

    07 Apr 2015 | Health Nutrition, A region on the move

    Lille-based Macopharma, a major specialist player in pharmaceuticals, has developed an automated culturing system to optimize preservation of pancreatic islets—cells that play a key role in treating diabetes.

    Macopharma innovation - Health- Lille Region

    Prisma—a pioneer in diabetes therapy

    Macopharma’s revolutionary Prisma (Pancreatic Islet System Automate unit) breaks new ground in biotherapy.  The product of four years of R&D, this new machine automatically preserves pancreatic islets, the insulin-secreting cells that are used to treat patients with type 1 diabetes.

    Patented technology, bold commercial roll-out

    Prisma uses three patented systems: a disposable medical device, a cell chamber that preserves the islets, and a specially optimized cell culture medium. “We’ve already deployed Prisma at three major cell therapy centers,” says Bruno Delorme, head of Biotherapy R&D at Macopharma. “These are Lille’s University Hospital Center (CHRU), our co-developer, plus units in Switzerland and in Sweden.

     

     

    Source: Les Echos, Nicole Buyse

     

     

    Back to news